Armata Pharmaceuticals, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Los Angeles, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Armata Pharmaceuticals, Inc. has filed 1,149 SEC EDGAR filings since 06 Feb 1996

SEC filing history

Showing 326-350 of 696 matching filings.

Per page
25
Current page
14
3

FORM 3 SUBMISSION

Filing date
16 May 2019
Reporting date
09 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
16 May 2019
Reporting date
09 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37544

FORM 8-K

Filing date
14 May 2019
Reporting date
14 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-44887

SCHEDULE 13G

Filing date
10 May 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37544

FORM 8-K

Filing date
10 May 2019
Reporting date
09 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37544

FORM 8-K

Filing date
08 May 2019
Reporting date
08 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-37544

DEFA14A

Filing date
01 May 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-37544

DEFA14A

Filing date
15 Apr 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFM14A File 001-37544

DEFM14A

Filing date
04 Apr 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
PREM14A File 001-37544

PRELIMINARY PROXY STATEMENT

Filing date
25 Mar 2019
Reporting date
08 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37544

FORM 8-K

Filing date
07 Feb 2019
Reporting date
05 Feb 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-44887

APHB 13GA

Filing date
30 Jan 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37544

FORM 8-K

Filing date
15 Jan 2019
Reporting date
14 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37544

FORM 8-K

Filing date
14 Jan 2019
Reporting date
14 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-37544

FORM 8-K

Filing date
14 Jan 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-44887

AMPLIPHI BIOSCIENCES CORPORATION

Filing date
10 Jan 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37544

8-K

Filing date
07 Jan 2019
Reporting date
07 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37544

FORM 8-K

Filing date
04 Jan 2019
Reporting date
03 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-37544

FORM 8-K

Filing date
04 Jan 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-44887

SABBY 13G-A APHB 1.04.19

Filing date
04 Jan 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-37544

8-K

Filing date
18 Dec 2018
Reporting date
17 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-37544

DEFINITIVE PROXY STATEMENT

Filing date
09 Nov 2018
Reporting date
17 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .